Perlstein Lab (PLab), a Public Benefit Corporation (PBC) that is accelerating precision drug discovery for 5,000+ rare genetic diseases. PLab’s innovative technology has been featured by Science, Science Friday, Popular Science, TechCrunch, and The Wall Street Journal. The company is initially focusing on childhood monogenic (single-gene) diseases.
